EXHIBIT 31.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934,
                             RULES 13A-14 AND 15D-14
                             AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Remedent USA, Inc. (the "Company") on
Form  10-QSB  for the  period  ending  September  30,  2004 as  filed  with  the
Securities and Exchange  Commission on the date hereof (the "Report"),  I, Robin
List, Chief Executive Officer of the Company,  certify, pursuant to Rules 13a-14
and 15-d14 of the  Securities  Exchange  Act of 1934 (the  "Exchange  Act"),  as
adopted pursuant to ss.302 of the Sarbanes-Oxley Act of 2002, that:

(1) I have reviewed this Report;

(2) Based on my knowledge,  this Report does not contain any untrue statement of
a  material  fact  or omit  to  state a  material  fact  necessary  to make  the
statements made, in light of the circumstances  under which such statements were
made, not misleading with respect to the period covered by this Report;

(3)  Based on my  knowledge,  the  financial  statements,  and  other  financial
information included in this Report, fairly present in all material respects the
financial condition, results of operations and cash flows of the Company, as of,
and for, the periods presented in this Report;

(4) I and the other  certifying  officers  of the Company  are  responsible  for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and have:

a. Designed such disclosure  controls and procedures,  or caused such disclosure
controls and  procedures to be designed  under our  supervision,  to ensure that
material  information  relating  to  the  Company,  including  any  consolidated
subsidiaries, is made known to us by others within those entities,  particularly
during the period in which  this  Report is being  prepared;  b.  Evaluated  the
effectiveness of the Company's  disclosure controls and procedures and presented
in this  Report  our  conclusions  about  the  effectiveness  of the  disclosure
controls  and  procedures,  as of the end of the period  covered by this  Report
based on such  evaluation;  and c.  Disclosed  in this  Report any change in the
Company's  internal  control over financial  reporting that occurred  during the
Company's most recent fiscal quarter (the Company's fourth fiscal quarter in the
case of an annual report) that has materially affected,  or is reasonably likely
to materially affect,  the Company's internal control over financial  reporting;
and

(5) I and the other certifying officers have disclosed, based on our most recent
evaluation  of internal  control  over  financial  reporting,  to the  Company's
auditors and to the audit  committee  of the  Company's  board of directors  (or
persons performing the equivalent functions):

a. All  significant  deficiencies  and  material  weaknesses  in the  design  or
operation of internal  control over  financial  reporting  which are  reasonably
likely to adversely affect the Company's ability to record,  process,  summarize
and report financial information; and

b. Any  fraud,  whether  or not  material,  that  involves  management  or other
employees who have a significant  role in the  Company's  internal  control over
financial reporting.




                                  /S/ ROBIN LIST
                                  --------------------------------
                                  Robin List,
                                  Chief Executive Officer
                                  November 24, 2004